Crigler-Najjar syndrome type I (CN-I) is a severe disorder caused by chronic nonhemolytic unconjugated hyperbilirubinemia due to the complete absence of hepatic bilirubin UDP-glucuronosyltransferase activity (UGT; Crigler and Najjar, 1952; Arias et al., 1969) . The disease is inherited as an autosomal recessive trait (Roy-Chowdhury et al., 1982) . Bilirubin levels in the serum reach more than 342 ~tmol/liter and the patients succumb to kernicterus during the neonatal period unless treated with phototherapy, plasmapheresis or liver transplantation (Wolkoff et al., 1979) . Treatment with phenobarbital has no effect on the bilirubin level of CN-I.
Bilirubin UGT exists as a tetramer on the luminal surface of the endoplasmic reticulum in liver cells (Peters et al., 1984) and it catalyzes the conversion of insoluble bilirubin to a water-soluble form by glucuronidation. Recently, cDNAs for rat and human bilirubin UGT were isolated (Sato et al., 1990; Ritter et al., 1991) and the structure of the gene for human bilirubin UGT in terms of exon-intron organization was determined (Ritter et al., 1992; Bosma et aL, 1992a) . The gene is located on chromosome 2 (van Es et al., 1993) and consists of five exons (Bosma et al., 1992a (Bosma et al., , 1994 . On the basis of the structure of the gene for human bilirubin UGT, the genetic backgrounds of patients with CN-I have been elucidated. While almost all reported patients with the disease have homozygous nonsense or deletion mutations in the coding region of the gene (Brierley and Burchell, 1993) , a few cases with homozygous missense mutations were found recently (Bosma et al., 1992b; Erps et al., 1994) . By screening, we found four patients who suffered from CN-I in Japan. We already reported that one of them, patient A, carried a homozygous nonsense mutation in exon 1 of the gene for bilirubin U G T (Aono et al., 1994) . We have now analyzed the genetic backgrounds of the other three patients, B, C, and D, and, as we report herein, all three patients have a mutation in exon 1 identical to that found in patient A.
The diagnosis of CN-I was based on a markedly elevated level of unconjugated bilirubin in the serum that did not respond to treatment with phenobarbital and on the absence of hepatic bilirubin U G T activity. Liver tissues were obtained from the patients by biopsy and bilirubin U G T activities were assayed. No bilirubin U G T activity was detected in patient B at 14 days after birth or in patient C at 5 months after birth by H P L C method (Kawade, 1980) . In patient D, no enzymatic activity was detected at 51 days after birth by the method of Heirwegh Since the mutation detected in patient B and his elder sister C were identical to each other, only the typical pattern from patient B is depicted. The wedges indicate the sites of mutations.
et al. (Van Roy and Heirwegh, 1968; Mizutani et al., 1980) . The total bilirubin level in the serum of each of the three patients B, C, and D exceeded 342 ~mol/ liter unless the patients were treated with phototherapy and the level was not lowered by administration of phenobarbital as much as 5 mg/kg/day. The bilirubin level in the serum of each patient is being maintained below 171 ~mol/liter by the phototherapy for 12 hr. The results of other liver function tests (ALT, AST, and albumin levels, ICG and BSP) and liver histological findings were normal in each patient. Blood samples were collected from patients B (9-year-old male), C (17-yearold female), D (15-year-old male) and their parents, and from three normal males for DNA analyses. Patient C was an elder sister of patient B. The entire first to fifth exons of the gene for bilirubin UGT of the patients and normal controls were amplified by PCR with specific primers (Aono et al., 1994) It is not clear which child (G or H) was produced by E and F. A cross indicates that a child died at birth. Vol. 40, No. 3, 1995 of patient A, we first expected that a novel nonsense or missense mutation at a position different from the mutation in patient A would be found in the gene of patient B (C). Unexpectedly, we found a mutation from C to A at position 840 (Fig. 1) , which was identical to the mutation in patient A (Aono et al., 1994) . Next we analyzed the DNA sequence of the gene for bilirubin UGT of patient D.
To our surprise, we found that patient D with CN-I also had the identical mutation at position 840 (Fig. 1) .
We promptly performed pedigree analysis of patients B (C) and D (Fig. 2) . From the analysis of patient B (C) (Fig. 2a) , it was determined that the mother's grandfather was the elder brother of the father's mother. In the case of patient D, the mother's and father's ancestor were related at more than five generations ahead of patient D (Fig. 2b) . More than one hundred years ago, a point mutation might have occurred at position 840 in the pedigree of patient D. The man carrying the mutation married twice and the mutated allele passed for four generations in two independent pedigrees (Fig. 2) . Unfortunately, without their knowledge of the relationship, the parents married and produced children with the homozygous nonsense mutation. While a clear relationship between the families of patient B (C) and patient D was not elucidated from the pedigree analysis, the two families have the same last name, suggesting that they might be distantly related. Since we could not gain the informed consent of patient A's family for pedigree analysis, the relationships between patient A and patient B (C) and that between patient A and patient D have not been clarified. However, it is noteworthy that all three families come from a small local area, the Mikawa district, in Japan. This fact strongly suggests that the three Japanese families with CN-I are distantly related.
